Cargando…
Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report
Immune checkpoint inhibitors (ICIs) have improved the clinical outcome of NSCLC. However, immune-related adverse events (irAEs) such as pneumonitis, thyroiditis, and colitis have been reported with the increasing use of ICIs. The diagnosis of irAEs relies on exclusion. With proper management, most p...
Autores principales: | Shen, Chia-I, Yeh, Yi-Chen, Chiu, Chao-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474266/ https://www.ncbi.nlm.nih.gov/pubmed/34590016 http://dx.doi.org/10.1016/j.jtocrr.2021.100156 |
Ejemplares similares
-
Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion
por: Shan, Yi, et al.
Publicado: (2017) -
Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of Nivolumab
por: Sawada, Ryo, et al.
Publicado: (2021) -
Adverse events after pleurodesis in patients with malignant pleural effusion
por: Terra, Ricardo Mingarini, et al.
Publicado: (2020) -
Alectinib-Induced Pleural and Pericardial Effusions in ALK-Positive NSCLC
por: Ulhoi, Maiken Parm, et al.
Publicado: (2021) -
An unusual cause of pleural effusion
por: Shih, Chi‐Wei, et al.
Publicado: (2021)